A suitable tool for analyzing glycans in biopharmaceutical manufacturing is the growing use of analytical enzymes known as exoglycosidases.
Christopher H. Taron
Advertisement
Christopher H. Taron is scientific director, Protein Expression and Modification Division, at New England Biolabs.
Articles by Christopher H. Taron
Advertisement
Latest Updated Articles
Improvement of Structural Profiling of N-glycans in BiologicsPublished: November 7th 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
2
Everything to Know About Pharmaceutical Tariffs in 2025
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
